Literature DB >> 24658401

The novel miR-9500 regulates the proliferation and migration of human lung cancer cells by targeting Akt1.

J K Yoo1, H Y Jung1, J M Lee1, H Yi1, S-H Oh2, H Y Ko3, H Yoo1, H-R Kim3, H Song3, S Kim3, J K Kim1.   

Abstract

MicroRNAs have crucial roles in lung cancer cell development. They regulate cell growth, proliferation and migration by mediating the expression of tumor suppressor genes and oncogenes. We identified and characterized the novel miR-9500 in human lung cancer cells. The miR-9500 forms a stem-loop structure and is conserved in other mammals. The expression levels of miR-9500 were reduced in lung cancer cells and lung cancer tissues compared with normal tissues, as verified by TaqMan miRNA assays. It was confirmed that the putative target gene, Akt1, was directly suppressed by miR-9500, as demonstrated by a luciferase reporter assay. The miR-9500 significantly repressed the protein expression levels of Akt1, as demonstrated via western blot, but did not affect the corresponding mRNA levels. Akt1 has an important role in lung carcinogenesis, and depletion of Akt1 has been shown to have antiproliferative and anti-migratory effects in previous studies. In the current study, the overexpression of miR-9500 inhibited cell proliferation and the expression of cell cycle-related proteins. Likewise, the overexpression of miR-9500 impeded cell migration in human lung cancer cells. In an in vivo assay, miR-9500 significantly suppressed Fluc expression compared with NC and ASO-miR-9500, suggesting that cell proliferation was inhibited in nude mice. Likewise, miR-9500 repressed tumorigenesis and metastasis by targeting Akt1. These data indicate that miR-9500 might be applicable for lung cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24658401      PMCID: PMC4207482          DOI: 10.1038/cdd.2014.33

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  50 in total

1.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.

Authors:  S M Hammond; E Bernstein; D Beach; G J Hannon
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

2.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.

Authors:  Yan Zeng; Rui Yi; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

3.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

4.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

5.  Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.

Authors:  J Xiong; Q Du; Z Liang
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

6.  MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.

Authors:  W Qin; P Dong; C Ma; K Mitchelson; T Deng; L Zhang; Y Sun; X Feng; Y Ding; X Lu; J He; H Wen; J Cheng
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

7.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

Review 8.  MicroRNAs in the pathogenesis of Lung Cancer.

Authors:  Xin Wu; Melissa G Piper-Hunter; Melissa Crawford; Gerard J Nuovo; Clay B Marsh; Gregory A Otterson; Serge P Nana-Sinkam
Journal:  J Thorac Oncol       Date:  2009-08       Impact factor: 15.609

9.  PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells.

Authors:  Jiachi Ma; Hirozumi Sawai; Nobuo Ochi; Yoichi Matsuo; Donghui Xu; Akira Yasuda; Hiroki Takahashi; Takehiro Wakasugi; Hiromitsu Takeyama
Journal:  Mol Cell Biochem       Date:  2009-05-13       Impact factor: 3.396

10.  Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.

Authors:  G A Bjerke; C-S Yang; H F Frierson; B M Paschal; D Wotton
Journal:  Oncogene       Date:  2013-09-02       Impact factor: 9.867

View more
  12 in total

1.  The novel miR-9501 inhibits cell proliferation, migration and activates apoptosis in non-small cell lung cancer.

Authors:  Yongyong Xi; Liang Wang; Chengcao Sun; Cuili Yang; Feng Zhang; Dejia Li
Journal:  Med Oncol       Date:  2016-10-12       Impact factor: 3.064

2.  Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.

Authors:  Simone Bsp Terra; Jin S Jang; Lintao Bi; Benjamin R Kipp; Jin Jen; Eunhee S Yi; Jennifer M Boland
Journal:  Mod Pathol       Date:  2016-05-13       Impact factor: 7.842

3.  miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.

Authors:  Shuo Zhang; Lei Gao; Asmitananda Thakur; Puyu Shi; Feng Liu; Jing Feng; Ting Wang; Yiqian Liang; Johnson J Liu; Mingwei Chen; Hui Ren
Journal:  Tumour Biol       Date:  2016-03-02

Review 4.  MicroRNAs in apoptosis, autophagy and necroptosis.

Authors:  Zhenyi Su; Zuozhang Yang; Yongqing Xu; Yongbin Chen; Qiang Yu
Journal:  Oncotarget       Date:  2015-04-20

5.  C-reactive protein levels in the perioperative period as a predictive marker of endoscopic recurrence after ileo-colonic resection for Crohn's disease.

Authors:  E Iaculli; M Agostini; L Biancone; C Fiorani; A Di Vizia; F Montagnese; S Sibio; A Manzelli; M Tesauro; A Rufini; G S Sica
Journal:  Cell Death Discov       Date:  2016-05-23

6.  HSP90: A Novel Target Gene of miRNA-628-3p in A549 Cells.

Authors:  Jieli Pan; Fusheng Jiang; Jia Zhou; Dehong Wu; Zhenhua Sheng; Meiya Li
Journal:  Biomed Res Int       Date:  2018-05-20       Impact factor: 3.411

7.  Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2.

Authors:  Yingfeng Tu; Li Liu; Dongliang Zhao; Youbin Liu; Xiaowei Ma; Yuhua Fan; Lin Wan; Tao Huang; Zhen Cheng; Baozhong Shen
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

8.  Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.

Authors:  Shuang Wei; Zun-Yi Zhang; Sheng-Ling Fu; Jun-Gang Xie; Xian-Sheng Liu; Yong-Jian Xu; Jian-Ping Zhao; Wei-Ning Xiong
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

9.  The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression.

Authors:  Cheng-Cao Sun; Shu-Jun Li; Feng Zhang; Ya-Dong Zhang; Zhen-Yu Zuo; Yong-Yong Xi; Liang Wang; De-Jia Li
Journal:  Mol Ther Nucleic Acids       Date:  2016-11-15       Impact factor: 10.183

10.  The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer.

Authors:  Seong Ho Jeon; Jung Ki Yoo; Chang Min Kim; Eun Su Lim; So Jeong Lee; Ji Min Lee; Seung-Hun Oh; Jin Kyeoung Kim
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.